The production department of the pharmaceutical company organizes special emergency rescue drills.
Release time:
2023-06-07
on may 23 and 26, the pharmaceutical company's production department manufacturing department 2, bulk drug workshop and qiubin preparation workshop respectively carried out fire safety drills, special emergency rescue drills for hazardous chemical leakage accidents, safety training and fire emergency drills.
Manufacturing Department 2 organized employees to conduct emergency evacuation drills to further understand how to use escape routes to escape the fire scene in a timely and rapid manner. At the same time, in order to further consolidate the effect, the relevant personnel of the safety and environment department also demonstrated the operation procedures of fire hydrants on the spot, and let the employees use them personally, so that the trainees can correctly master the operation methods of fire fighting equipment. The purpose of the special emergency rescue drill for
hazardous chemical leakage accident is to quickly and effectively deal with the over-temperature and over-pressure leakage accidents in the production process of the bulk drug workshop, to deal with emergencies through an efficient organization system, and to control and reduce personnel and property damage in the shortest time and the most effective way. This exercise simulated that the personnel on duty in the automatic control room found that the steel platform on the north side of the anti-tumor bulk drug line replaced the reaction tank with a high-pressure alarm. At the same time, the automatic control emergency venting failed and the automatic control system failed. During the manual switching operation of the on-site personnel, the emergency plan was immediately started in the bulk drug workshop due to over-temperature and over-pressure in the kettle, equipment sealing problems and thionyl chloride steam leakage, the comprehensive coordination group, engineering rescue group, on-site rescue group, evacuation protection group and logistics support group handled the accident in an orderly manner, and the accident was controlled and relieved. By personally participating in on-site drills and drill summary analysis, the employees not only enhanced their knowledge of emergency rescue, but also had further practical experience in emergency site handling, emergency evacuation, correct escape and rescue, etc., which can effectively respond to emergencies in the future. Reduce accident hazards and provide protection.
Qiubin Preparation Workshop organized all staff to re-learn and identify the hazard sources in the workshop equipment and daily production activities, implement the safety concept of "all accidents can be prevented and controlled, and focus on prevention", continuously deepen the impression of employees, strengthen the awareness of safe operation, and ensure production safety and life safety. Relevant personnel of the Ministry of Security led all personnel to learn the spirit of the group company's documents on "safe production month" and warned employees that "safety is due to vigilance and accidents are due to paralysis" by explaining a series of production accidents. To ensure safe operation is to protect one's own life. After the meeting, the preparation workshop also organized employees to carry out fire safety drills and emergency rescue, from the beginning of the fire report, safe evacuation and escape, alarm call for help, to the use of fire fighting equipment teaching, emergency rescue team rescue, and then to the whole process of cardiopulmonary resuscitation of the wounded Drill, improve emergency response ability, run-in coordination ability, exercise the ability to deal with accidents, and enhance the ability of all employees to survive safely in accidents. (Lu Junhua, Jin Mengyang, Hu Liyu, Hong Zhiwei, Chen Weilin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page